Drug Use Review (DUR) Board

The Drug Use Review Board oversees Hawaii's Medicaid pharmacy program, reviewing drug utilization data to promote clinically appropriate, safe, and cost-effective prescribing. It establishes criteria for prospective and retrospective drug use review and recommends interventions when prescribing patterns fall outside accepted standards. The board reports findings to CMS and the state legislature.

This board helps ensure that Medicaid recipients in Hawaii receive medications that are both effective and safe, which can affect coverage decisions and pharmacy benefit policies statewide. Healthcare providers and patients with an interest in Medicaid pharmacy policy can submit public testimony.